{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:59:01Z","timestamp":1777888741817,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T00:00:00Z","timestamp":1773532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-41108-y","type":"journal-article","created":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T05:06:39Z","timestamp":1773551199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipodystrophy and associated factors among patients with diabetes receiving insulin therapy: a multicenter study in Ethiopia"],"prefix":"10.1038","volume":"16","author":[{"given":"Zegaye Agmassie","family":"Bazezew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tirsit Ketsela","family":"Zeleke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chernet Tafere","family":"Negesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gashaw Binega","family":"Mekonnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"issue":"14","key":"41108_CR1","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMra1110560","volume":"367","author":"KS Polonsky","year":"2012","unstructured":"Polonsky, K. S. The past 200 years in diabetes. N. Engl. J. Med. 367 (14), 1332\u20131340 (2012).","journal-title":"N. Engl. J. Med."},{"key":"41108_CR2","doi-asserted-by":"publisher","first-page":"838027","DOI":"10.3389\/fendo.2022.838027","volume":"13","author":"S Safiri","year":"2022","unstructured":"Safiri, S. et al. Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990\u20132019: results from the global burden of disease study 2019. Front. Endocrinol. 13, 838027 (2022).","journal-title":"Front. Endocrinol."},{"key":"41108_CR3","unstructured":"<2023_ada_diabete_standards_of_care_in_diabetes_diab_care.pdf&gt."},{"issue":"1","key":"41108_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2213-8587(18)30303-6","volume":"7","author":"S Basu","year":"2019","unstructured":"Basu, S. et al. Estimation of global insulin use for type 2 diabetes, 2018\u201330: a microsimulation analysis. lancet Diabetes Endocrinol. 7 (1), 25\u201333 (2019).","journal-title":"lancet Diabetes Endocrinol."},{"key":"41108_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2337\/cd17-0119","volume":"36","author":"CARE I","year":"2018","unstructured":"CARE I. Standards of medical care in diabetes\u20142018 abridged for primary care providers. Clin. Diabetes. 36, 14\u201337 (2018).","journal-title":"Clin. Diabetes"},{"issue":"02","key":"41108_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1055\/s-0029-1211431","volume":"104","author":"H Hauner","year":"1996","unstructured":"Hauner, H., Stockamp, B. & Haastert, B. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors. Exp. Clin. Endocrinol. Diabetes. 104 (02), 106\u2013110 (1996).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"6","key":"41108_CR7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.therap.2021.04.002","volume":"76","author":"K Wang","year":"2021","unstructured":"Wang, K., Zhang, S., Liu, C. & Chen, Y. A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy. Therapies 76 (6), 617\u2013628 (2021).","journal-title":"Therapies"},{"issue":"1","key":"41108_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40064-016-1978-y","volume":"5","author":"S Gentile","year":"2016","unstructured":"Gentile, S., Guarino, G., Giancaterini, A., Guida, P. & Strollo, F. A suitable palpation technique allows to identify skin lipohypertrophic lesions in insulin-treated people with diabetes. Springerplus 5 (1), 1\u20137 (2016).","journal-title":"Springerplus"},{"issue":"2","key":"41108_CR9","doi-asserted-by":"publisher","first-page":"e002553","DOI":"10.1136\/bmjdrc-2021-002553","volume":"9","author":"R Hashem","year":"2021","unstructured":"Hashem, R. et al. Characteristics and morphology of lipohypertrophic lesions in adults with type 1 diabetes with ultrasound screening: an exploratory observational study. BMJ Open. Diabetes Res. Care. 9 (2), e002553 (2021).","journal-title":"BMJ Open. Diabetes Res. Care"},{"key":"41108_CR10","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.2147\/DMSO.S282926","volume":"13","author":"Y Thewjitcharoen","year":"2020","unstructured":"Thewjitcharoen, Y. et al. Prevalence, risk factors, and clinical characteristics of lipodystrophy in insulin-treated patients with diabetes: an old problem in a new era of modern insulin. Diabetes Metabolic Syndrome Obesity: Targets Therapy. 13, 4609 (2020).","journal-title":"Diabetes Metabolic Syndrome Obesity: Targets Therapy"},{"issue":"1","key":"41108_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/adc.2010.183731","volume":"96","author":"A Babiker","year":"2011","unstructured":"Babiker, A. & Datta, V. Lipoatrophy with insulin analogues in type I diabetes. Arch. Dis. Child. 96 (1), 101\u2013102 (2011).","journal-title":"Arch. Dis. Child."},{"issue":"6230","key":"41108_CR12","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1136\/bmj.280.6230.1500","volume":"280","author":"W Reeves","year":"1980","unstructured":"Reeves, W., Allen, B. & Tattersall, R. Insulin-induced lipoatrophy: evidence for an immune pathogenesis. Br. Med. J. 280 (6230), 1500\u20131503 (1980).","journal-title":"Br. Med. J."},{"issue":"10","key":"41108_CR13","first-page":"1196","volume":"15","author":"Z Hajheydari","year":"2011","unstructured":"Hajheydari, Z., Kashi, Z., Akha, O. & Akbarzadeh, S. Frequency of lipodystrophy induced by recombinant human insulin. Eur. Rev. Med. Pharmacol. Sci. 15 (10), 1196\u20131201 (2011).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"8","key":"41108_CR14","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.2337\/diacare.28.8.2025","volume":"28","author":"U-B Johansson","year":"2005","unstructured":"Johansson, U-B. et al. Impaired absorption of insulin aspart from lipohypertrophic injection sites. Diabetes Care. 28 (8), 2025\u20132027 (2005).","journal-title":"Diabetes Care"},{"issue":"7","key":"41108_CR15","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3390\/children9071087","volume":"9","author":"F Lombardo","year":"2022","unstructured":"Lombardo, F. et al. The impact of insulin-induced lipodystrophy on glycemic variability in pediatric patients with type 1 diabetes. Children 9 (7), 1087 (2022).","journal-title":"Children"},{"issue":"9","key":"41108_CR16","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.2337\/dc16-0610","volume":"39","author":"S Famulla","year":"2016","unstructured":"Famulla, S. et al. Insulin injection into lipohypertrophic tissue: blunted and more variable insulin absorption and action and impaired postprandial glucose control. Diabetes Care. 39 (9), 1486\u20131492 (2016).","journal-title":"Diabetes Care"},{"issue":"3","key":"41108_CR17","first-page":"224","volume":"15","author":"AN AlJaber","year":"2020","unstructured":"AlJaber, A. N., Sales, I., Almigbal, T. H., Wajid, S. & Batais, M. A. The prevalence of lipohypertrophy and its associated factors among Saudi patients with type 2 diabetes mellitus. J. Taibah Univ. Med. Sci. 15 (3), 224\u2013231 (2020).","journal-title":"J. Taibah Univ. Med. Sci."},{"issue":"7","key":"41108_CR18","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jsps.2021.04.028","volume":"29","author":"S Selvadurai","year":"2021","unstructured":"Selvadurai, S. et al. Impact of pharmacist insulin injection re-education on glycemic control among type II diabetic patients in primary health clinics. Saudi Pharm. J. 29 (7), 670\u2013676 (2021).","journal-title":"Saudi Pharm. J."},{"issue":"2","key":"41108_CR19","doi-asserted-by":"publisher","first-page":"e33997","DOI":"10.5812\/ijem.33997","volume":"14","author":"S Gentile","year":"2016","unstructured":"Gentile, S., Strollo, F. & Ceriello, A. Lipodistrophy and associated risk factors in insulin-treated people with diabetes. Int. J. Endocrinol. metabolism. 14 (2), e33997 (2016).","journal-title":"Int. J. Endocrinol. metabolism"},{"issue":"1","key":"41108_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/dia.2016.0334","volume":"19","author":"L Ji","year":"2017","unstructured":"Ji, L. et al. Lipohypertrophy in China: prevalence, risk factors, insulin consumption, and clinical impact. Diabetes. Technol. Ther. 19 (1), 61\u201367 (2017).","journal-title":"Diabetes. Technol. Ther."},{"issue":"23\u201324","key":"41108_CR21","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1111\/jocn.13801","volume":"26","author":"I Hernar","year":"2017","unstructured":"Hernar, I., Haltbakk, J. & Brostr\u00f6m, A. Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy. J. Clin. Nurs. 26 (23\u201324), 4583\u20134596 (2017).","journal-title":"J. Clin. Nurs."},{"issue":"6","key":"41108_CR22","doi-asserted-by":"publisher","first-page":"521","DOI":"10.33546\/bnj.2246","volume":"8","author":"RA Nain","year":"2022","unstructured":"Nain, R. A. & Thomas, D. C. Lipohypertrophy prevalence and its associated risk factors in insulin-treated patients with type 2 diabetes in North Borneo, Malaysia. Belitung Nurs. J. 8 (6), 521 (2022).","journal-title":"Belitung Nurs. J."},{"key":"41108_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s13410-020-00889-2","volume":"41","author":"R Kumar","year":"2021","unstructured":"Kumar, R. et al. Lipohypertrophy in insulin injecting patients with diabetes mellitus: an under-recognized barrier for glycemic control. Int. J. Diabetes Developing Ctries. 41, 329\u2013336 (2021).","journal-title":"Int. J. Diabetes Developing Ctries."},{"issue":"10","key":"41108_CR24","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1111\/dme.13764","volume":"35","author":"J Kapeluto","year":"2018","unstructured":"Kapeluto, J., Paty, B., Chang, S. & Meneilly, G. Ultrasound detection of insulin-induced lipohypertrophy in Type 1 and Type 2 diabetes. Diabet. Med. 35 (10), 1383\u20131390 (2018).","journal-title":"Diabet. Med."},{"key":"41108_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.51866\/oa.100","volume":"18","author":"A Hawa","year":"2023","unstructured":"Hawa, A. et al. Prevalence and associated factors of lipohypertrophy in insulin-injected patients with diabetes in selected primary care clinics in Peninsular Malaysian: A cross-sectional study. Malaysian Family Physician: Official J. Acad. Family Physicians Malaysia. 18, 37 (2023).","journal-title":"Malaysian Family Physician: Official J. Acad. Family Physicians Malaysia"},{"issue":"1","key":"41108_CR26","first-page":"209","volume":"39","author":"A Nawaz","year":"2023","unstructured":"Nawaz, A., Hasham, M. A., Shireen, M. & Iftikhar, M. Prevalence of lipohypertrophy and its associations in insulin-treated diabetic patients. Pakistan J. Med. Sci. 39 (1), 209 (2023).","journal-title":"Pakistan J. Med. Sci."},{"key":"41108_CR27","doi-asserted-by":"crossref","unstructured":"Thewjitcharoen, Y. et al. Prevalence, risk factors, and clinical characteristics of lipodystrophy in insulin-treated patients with diabetes: an old problem in a new era of modern insulin. Diabetes, Metabolic Syndrome and Obesity. 4609-20. (2020).","DOI":"10.2147\/DMSO.S282926"},{"key":"41108_CR28","doi-asserted-by":"crossref","unstructured":"Lin, Y., Lin, L., Wang, W., Hong, J., & Zeng, H. Insulin-related lipohypertrophy: Ultrasound characteristics, risk factors, and impact of glucose fluctuations. Endocrine, 75, 1\u20138 (2022).","DOI":"10.21203\/rs.3.rs-894169\/v1"},{"issue":"2","key":"41108_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/jmgims.jmgims_58_19","volume":"25","author":"V Brijeetha","year":"2020","unstructured":"Brijeetha, V., Fernandes, J. E. & Idiculla, J. Prediction of Lipohypertrophy in Patients with Diabetes Mellitus. J. Mahatma Gandhi Inst. Med. Sci. 25 (2), 86\u201389 (2020).","journal-title":"J. Mahatma Gandhi Inst. Med. Sci."},{"key":"41108_CR30","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s13300-020-00876-0","volume":"11","author":"S Gentile","year":"2020","unstructured":"Gentile, S. et al. Insulin-induced skin lipohypertrophy in type 2 diabetes: a multicenter regional survey in Southern Italy. Diabetes Therapy. 11, 2001\u20132017 (2020).","journal-title":"Diabetes Therapy"},{"key":"41108_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13300-018-0561-7","volume":"10","author":"A Deeb","year":"2019","unstructured":"Deeb, A. et al. Impact of insulin injection and infusion routines on lipohypertrophy and glycemic control in children and adults with diabetes. Diabetes Therapy. 10, 259\u2013267 (2019).","journal-title":"Diabetes Therapy"},{"issue":"8","key":"41108_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/pdi.91","volume":"17","author":"TM Partanen","year":"2000","unstructured":"Partanen, T. M. & Rissanen, A. Insulin injection practices. Practical Diabetes Int. 17 (8), 252\u2013254 (2000).","journal-title":"Practical Diabetes Int."},{"key":"41108_CR33","doi-asserted-by":"publisher","first-page":"738179","DOI":"10.3389\/fpubh.2021.738179","volume":"9","author":"M Shen","year":"2021","unstructured":"Shen, M. et al. A systematic survey of physicians\u2019 insights into lipohypertrophy. Front. Public. Health. 9, 738179 (2021).","journal-title":"Front. Public. Health"},{"issue":"2","key":"41108_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/ijem.ijem_407_21","volume":"26","author":"M Sharma","year":"2022","unstructured":"Sharma, M. et al. Effect of reuse of insulin needle on glycaemic control and related complications in children with type 1 diabetes mellitus: A prospective observational study. Indian J. Endocrinol. Metabol. 26 (2), 167\u2013172 (2022).","journal-title":"Indian J. Endocrinol. Metabol."},{"key":"41108_CR35","unstructured":"Volkova, N., Davidenko, I., Rudakova, J. & Segida, K. (eds) Ultrasonography of insulin injection sites in diabetic patients: a new method of lipohypertrophy diagnostics. Endocrine reviews Conference: 95th annual meeting and expo of the Endocrine Society, ENDO; (2013)."},{"key":"41108_CR36","doi-asserted-by":"publisher","first-page":"356496","DOI":"10.3389\/fendo.2018.00638","volume":"9","author":"A Barola","year":"2018","unstructured":"Barola, A., Tiwari, P., Bhansali, A., Grover, S. & Dayal, D. Insulin-related lipohypertrophy: lipogenic action or tissue trauma? Front. Endocrinol. 9, 356496 (2018).","journal-title":"Front. Endocrinol."},{"key":"41108_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13300-016-0161-3","volume":"7","author":"AA Al Hayek","year":"2016","unstructured":"Al Hayek, A. A., Robert, A. A., Braham, R. B. & Al Dawish, M. A. Frequency of lipohypertrophy and associated risk factors in young patients with type 1 diabetes: a cross-sectional study. Diabetes Therapy. 7, 259\u2013267 (2016).","journal-title":"Diabetes Therapy"},{"issue":"2","key":"41108_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.15171\/jcs.2018.011","volume":"7","author":"HA S\u00fcr\u00fcc\u00fc","year":"2018","unstructured":"S\u00fcr\u00fcc\u00fc, H. A. & Arslan, H. O. Lipohypertrophy in individuals with type 2 diabetes: prevalence and risk factors. J. Caring Sci. 7 (2), 67 (2018).","journal-title":"J. Caring Sci."},{"issue":"5","key":"41108_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.diabet.2013.05.006","volume":"39","author":"M Blanco","year":"2013","unstructured":"Blanco, M., Hern\u00e1ndez, M., Strauss, K. & Amaya, M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes Metab. 39 (5), 445\u2013453 (2013).","journal-title":"Diabetes Metab."},{"issue":"4","key":"41108_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jcte.2014.07.006","volume":"1","author":"G Grassi","year":"2014","unstructured":"Grassi, G., Scuntero, P., Trepiccioni, R., Marubbi, F. & Strauss, K. Optimizing insulin injection technique and its effect on blood glucose control. J. Clin. Translational Endocrinol. 1 (4), 145\u2013150 (2014).","journal-title":"J. Clin. Translational Endocrinol."},{"issue":"5","key":"41108_CR41","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1463-1326.2008.00972.x","volume":"11","author":"J Overland","year":"2009","unstructured":"Overland, J. et al. Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring system. Diabetes Obes. Metabolism. 11 (5), 460\u2013463 (2009).","journal-title":"Diabetes Obes. Metabolism"},{"issue":"2","key":"41108_CR42","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4183\/aeb.2022.202","volume":"18","author":"H Gunhan","year":"2022","unstructured":"Gunhan, H., Elbasan, O., Imre, E. & Yavuz, D. G. Lipodystrophy frequency according to insulin treatment regimen in type 2 diabetic patients: Is insulin injection frequency matters in analog insulin era? Acta Endocrinol. (Bucharest). 18 (2), 202 (2022).","journal-title":"Acta Endocrinol. (Bucharest)"},{"key":"41108_CR43","doi-asserted-by":"crossref","unstructured":"Korkmaz, F. N., Canpolat, A. G. & G\u00fcll\u00fc, S. Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes. Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed). 69(5): 354\u2013361. (2022).","DOI":"10.1016\/j.endien.2022.05.006"},{"key":"41108_CR44","doi-asserted-by":"crossref","unstructured":"Huang, J., et al. Lipohypertrophy and insulin: An old dog that needs new tricks. Endocrine Practice, 29, 670\u2013699 (2023).","DOI":"10.1016\/j.eprac.2023.04.006"},{"key":"41108_CR45","unstructured":"Thomas, J., Meal, A. & Adams, G. G. Relationship between Lipohypertrophy, Injection Techniques and Education in adults with Type 2 Diabetes: A Systematic Review. (2019)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41108-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41108-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:56:11Z","timestamp":1777611371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41108-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41108"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41108-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,15]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13560"}}